Announcements Trials
Browse Landscape

Status

Completed 32Withdrawn 5Unknown 5Recruiting 3Terminated 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 3Lymphoid 3Genitourinary 3CNS 3Plasma cell 2Myeloid 2Breast 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 2Neoplasms 1Fatigue 1

Interventions

Trastuzumab 86Cyclophosphamide 67Capecitabine 67Paclitaxel 63Docetaxel 57Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 40Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 18atezolizumab 17Everolimus 17130-nm albumin-bound paclitaxel 17pertuzumab 16Epirubicin 16palbociclib 15eribulin 14Magnetic Resonance Spectroscopy 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Therapeutics × Breast × Clear all
NCT01357863 2018-09-14

(TYCO1)

GlaxoSmithKline

Terminated
3 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT00909662 2015-10-02

Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers

Case Comprehensive Cancer Center

Terminated
18 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡